Originally published as JCO Early Release 10.1200/JCO.2008.21.1680 on April 29 2009

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a colleague Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Save to my personal folders Download to citation manager Rights & Permissions Citing Articles Citing Articles via HighWire Google Scholar Articles by Goss, E. Articles by Raghavan, D. PubMed PubMed Citation Articles by Goss, E. Articles by Raghavan, D. Related Articles Related Article Social Bookmarking                            What's this?

American Society of Clinical Oncology Policy Statement: Disparities in Cancer Care

Turner & Goss LLP, Washington, DC; Arizona Cancer Center, Tucson, AZ; Memorial Sloan-Kettering Cancer Center, New York, NY; American Society of Clinical Oncology, Alexandria, VA; American Cancer Society, Atlanta, GA; and the Cleveland Clinic Taussig Cancer Center, Cleveland, OH.

Corresponding author: Dana Wollins, MGC, American Society of Clinical Oncology, Cancer Policy and Clinical Affairs, 2318 Mill Rd, Suite 800, Alexandria, VA 22314, e-mail: dana.wollins{at}asco.org.

The American Society of Clinical Oncology (ASCO) has embarked on an intensive campaign to integrate elimination of cancer health disparities into the Society's overall mission and activities. Key components of this commitment are enhancing awareness of disparities; improving access to care; and supporting research on health disparities. Major objectives are to advance the education of the oncology community in the care of patients from underserved and minority populations; increase the diversity of the clinical oncology workforce as a requisite to improving access to cancer care for the underserved; and support research in the area of health disparities. Racial and ethnic disparities in cancer care are an issue of critical importance to ASCO, the oncology community, and our society at large. The health disparities initiative outlined herein enunciates ASCO's dedication to eliminating disparities in cancer care and discusses our multipronged approach for addressing disparities within the clinical oncology community. ASCO is committed to collaborating with the diverse community of stakeholders to undertake the following: develop policies to guarantee equal access to quality health care, with special emphasis on reducing insurance and economic barriers to cancer care; develop a comprehensive plan to increase awareness of racial and ethnic disparities in cancer care; execute a strategy to enhance the supply of minority physicians and to improve the training of the oncology workforce to meet the needs of racially and ethnically diverse cancer patients; increase prioritization of public and private research on cancer care disparities; develop mechanisms to increase participation of racially and ethnically diverse populations in cancer clinical trials; and support initiatives to enhance patients' involvement in their cancer care.

Approved by the Board of Directors on September 4, 2008.

Authors' disclosures of potential conflicts of interest and author contributions are found at the end of this article.

CiteULike    Complore    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

Related Article

• Future of Cancer Incidence in the United States: Burdens Upon an Aging, Changing Nation
  Benjamin D. Smith, Grace L. Smith, Arti Hurria, Gabriel N. Hortobagyi, and Thomas A. Buchholz
  JCO 2009 27: 2758-2765 [Abstract] [Full Text]

This article has been cited by other articles:

				ASCO Announces New Program Designed to Increase Workforce Diversity and Reduce Cancer Care Disparities J. Oncol. Pract, November 1, 2009; 5(6): 315 - 317. [Full Text] [PDF]

				C. S. Lathan Commentary: One Small Step J. Oncol. Pract, November 1, 2009; 5(6): 317 - 318. [Full Text] [PDF]

				M. N. Neuss The Truth, the Whole Truth, and the Medical Record J. Oncol. Pract, July 1, 2009; 5(4): 175 - 176. [Full Text] [PDF]